Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy

• Hauptverfasser: Mina Kabiri PhD (Verfasst von), Alison Sexton Ward PhD (Verfasst von), Abhilasha Ramasamy MS, MSc (Verfasst von), Rebecca Kee BA (Verfasst von), Rahul Ganguly PhD (Verfasst von), Brian Gabriel Smolarz MD, MS (Verfasst von), Tracy Zvenyach PhD, NP (Verfasst von), James R. Baumgardner PhD (Verfasst von), Dana P. Goldman PhD (Verfasst von)
• Format: Buch
• Veröffentlicht: SAGE Publishing, 2021-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

While substantial public health investment in anti-smoking initiatives has had demonstrated benefits on health and fiscal outcomes, similar investment in reducing obesity has not been undertaken, despite the substantial burden obesity places on society. Anti-obesity medications (AOMs) are poorly pre...